Brief: VBI Vaccines Announces Health Canada Approval For Prehevbrio
08/12/2022 14:09
Dec 8 (Reuters) - VBI Vaccines Inc VBIV.O :
* VBI VACCINES ANNOUNCES HEALTH CANADA APPROVAL FOR
PREHEVBRIO™
FOR THE PREVENTION OF HEPATITIS B IN ADULTS
* VBI VACCINES-EXPECTED HEPATITIS D ALSO BE PREVENTED BY
IMMUNIZATION WITH PREHEVBRIO AS HEPATITIS D DOES NOT OCCUR IN
ABSENCE OF HEPATITIS B INFECTION
Source: (shorturl.at/bmxX6)
Further company coverage: VBIV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VBI Vaccines
See all newsBrief: VBI Vaccines Provides Update On Its Restructuring Proceedings
Brief: Vbi Vaccines Announces New Tumor Response Data From Ongoing Randomized Controlled Phase 2B Study Of Vbi-1901 In Recurrent Glioblastoma Patients
VBI Vaccines Inc reports results for the quarter ended in March - Earnings Summary
Brief: VBI Vaccines Says Entered At Market Offering Deal For Gross Proceeds Of Up To $8.5 Mln
Brief: VBI Vaccines Q1 Adjusted EPS USD -0.55